Ensysce Biosciences, Inc. (ENSC) — Stock Valuation & Research

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose. The company leverages two primary technological frameworks: the Trypsin Activated Abuse Protection (TAAP) platform, which creates opioid prodrugs designed to resist abuse, and the Multi-Pill Abuse Resistance (MPAR) platform, engineered to offer protection against overdose through its advanced opioid prodrug technology. Ensysce's pipeline…

ENSC key statistics

Price$0.37
Market cap$7.15M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range0.23-2.17
Beta1.02

Explore ENSC's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.